UnitedHealth, Cigna stocks fall after Raymond James downgrades, citing tripledemic and policy concerns

UnitedHealth Group Inc. shares UNH,
+2.85%
Down 0.5%, Cigna Corp.CI,
+2.28%
Raymond James analyst John Ransom cites concerns that the ‘triple disease’ of influenza, RSV (respiratory syncytial virus) and COVID could lead to higher than expected health care loss rates , fell 2.3% in pre-market trading on Monday after downgrading health insurers (MLR).The ransom is also used by Medicare Advantage advance notice and Risk-Adjusted Data Verification (RADV) Final Rule.[T]The general view is that the near-ideal combination of factors in 2022 (declining medical trends, higher-than-expected MA rate increases, rotation to US-centric defensive stocks) is unlikely to repeat itself.” Ransom wrote in a note to customers. He downgraded the two companies, maintaining a price target of $615 for UnitedHealth and $370 for Cigna, which he’s up 5.6% year-to-date and Cigna’s 39.0% year-to-date. It is rising. Select Sector ETF XLV,
+1.21%
Dow Jones Industrial Average DJIA, down 4.5%
+0.59%
decreased by 7.1%.